2020
DOI: 10.1016/j.vetmic.2020.108589
|View full text |Cite
|
Sign up to set email alerts
|

Marek’s disease virus as a CRISPR/Cas9 delivery system to defend against avian leukosis virus infection in chickens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…Poultry is highly susceptible to viruses, such as MDV (Mark's disease virus), the highly pathogenic ALV-J (Avian leukosis virus J) [72], and AIV (avian influenza virus) [73], which all have fast transmission speeds and high mortality rates. Koslova et al successfully bred chNHE1-KO homozygous mutant chickens resistant to ALV infection using CRISPR-Cas9 [74].…”
Section: Application Of Crispr-cas9 Technology In Chicken Genetic Bre...mentioning
confidence: 99%
“…Poultry is highly susceptible to viruses, such as MDV (Mark's disease virus), the highly pathogenic ALV-J (Avian leukosis virus J) [72], and AIV (avian influenza virus) [73], which all have fast transmission speeds and high mortality rates. Koslova et al successfully bred chNHE1-KO homozygous mutant chickens resistant to ALV infection using CRISPR-Cas9 [74].…”
Section: Application Of Crispr-cas9 Technology In Chicken Genetic Bre...mentioning
confidence: 99%
“…Though the knockdowns observed were relatively small, with an average reduction of around 20 -25% per construct, this suggests that miRNA linked shRNA expression could be further developed for RNAi based viral targeting applications in vivo, such as by linking shRNA expression to expression of innate immune response genes both in vitro and in vivo (Challagulla et al, 2022). As a more specific alternative to RNAi-based knockdown, several studies have developed CRISPR/Cas-based systems for direct viral genome targeting in avian cells (K. Liu et al, 2020;Challagulla, Jenkins, et al, 2021). To ensure greater antiviral efficacy, these systems commonly target multiple loci within genes key to viral replication, as these genes are more functionally conserved and thus less likely to develop escape mutations which could inhibit effective viral targeting.…”
Section: Using Shrnas Cas9 and Cas13 To Directly Target Pathogensmentioning
confidence: 99%
“…These include the Cas12 effectors with both DNA and RNA targeting activity or the exclusively RNA targeting Cas13 effector proteins ( Zetsche et al, 2015;Abudayyeh et al, 2017). A similarly wide variety of systems have been utilised for delivery and expression of the CRISPR system in avian models, including transposon vectors, plasmid vectors or modified viral vectors such as adenovirus or Marek's Disease Virus (MDV) (Abu-Bonsrah et al, 2016;Lee et al, 2019;Liu et al, 2020). To generate CRISPR based homozygous edited in vivo knockout models, these systems are most commonly used to create transgenic PGC cultures, which are then reinserted into host embryos as described above and crossbred to produce homozygous transgenic offspring (Figure 1).…”
mentioning
confidence: 99%
“…Other herpesvirus vaccine vectors such as duck enteritis virus (DEV) 133,134 and ILTV 135 have also been developed via NHEJ-CRISPR-Cas9 and Cre-Lox Systems. Recombinant MDV vector carrying all the CRISPR-Cas9 components using an attenuated MDV vaccine strain (814 strain) for in vivo editing of reticuloendotheliosis virus (REV) and avian leukosis virus subgroup J (ALV-J) infection have recently been reported, 136,137 providing efficient delivery of CRISPR components into chickens, inducing a drastic reduction of REV and ALV-J viral load, significantly diminishing clinical disease.…”
Section: Herpesvirusesmentioning
confidence: 99%